Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 104776 | 25.91 |
09:34 ET | 69476 | 25.99 |
09:36 ET | 72507 | 25.82 |
09:38 ET | 38801 | 25.74 |
09:39 ET | 28844 | 25.69 |
09:41 ET | 25269 | 25.765 |
09:43 ET | 10599 | 25.67 |
09:45 ET | 19964 | 25.66 |
09:48 ET | 23802 | 25.77 |
09:50 ET | 22094 | 25.93 |
09:52 ET | 44873 | 26.0399 |
09:54 ET | 17683 | 25.955 |
09:56 ET | 18976 | 26.028 |
09:57 ET | 10759 | 26.038 |
09:59 ET | 15935 | 25.96 |
10:01 ET | 18679 | 25.935 |
10:03 ET | 24568 | 25.735 |
10:06 ET | 25398 | 25.7 |
10:08 ET | 30130 | 25.765 |
10:10 ET | 14849 | 25.62 |
10:12 ET | 47624 | 25.3847 |
10:14 ET | 49195 | 25.27 |
10:15 ET | 26871 | 25.16 |
10:17 ET | 26293 | 25.35 |
10:19 ET | 33430 | 25.3 |
10:21 ET | 28487 | 25.45 |
10:24 ET | 16837 | 25.446 |
10:26 ET | 9233 | 25.48 |
10:28 ET | 11307 | 25.51 |
10:30 ET | 12412 | 25.58 |
10:32 ET | 13813 | 25.46 |
10:33 ET | 12246 | 25.37 |
10:35 ET | 6147 | 25.37 |
10:37 ET | 9209 | 25.45 |
10:39 ET | 6609 | 25.49 |
10:42 ET | 12976 | 25.5 |
10:44 ET | 14665 | 25.525 |
10:46 ET | 8518 | 25.495 |
10:48 ET | 22182 | 25.57 |
10:50 ET | 15240 | 25.615 |
10:51 ET | 5777 | 25.56 |
10:53 ET | 11069 | 25.56 |
10:55 ET | 3443 | 25.52 |
10:57 ET | 10200 | 25.475 |
11:00 ET | 12923 | 25.49 |
11:02 ET | 13915 | 25.475 |
11:04 ET | 8107 | 25.48 |
11:06 ET | 6068 | 25.4 |
11:08 ET | 20138 | 25.34 |
11:09 ET | 12364 | 25.33 |
11:11 ET | 8420 | 25.31 |
11:13 ET | 11659 | 25.345 |
11:15 ET | 28469 | 25.35 |
11:18 ET | 11278 | 25.365 |
11:20 ET | 5872 | 25.3502 |
11:22 ET | 5232 | 25.335 |
11:24 ET | 7398 | 25.29 |
11:26 ET | 9929 | 25.2 |
11:27 ET | 10835 | 25.21 |
11:29 ET | 2489 | 25.23 |
11:31 ET | 10027 | 25.18 |
11:33 ET | 5843 | 25.29 |
11:36 ET | 6961 | 25.295 |
11:38 ET | 14841 | 25.385 |
11:40 ET | 22725 | 25.37 |
11:42 ET | 3178 | 25.31 |
11:44 ET | 9933 | 25.245 |
11:45 ET | 5505 | 25.3008 |
11:47 ET | 10366 | 25.22 |
11:49 ET | 5050 | 25.2 |
11:51 ET | 3808 | 25.25 |
11:54 ET | 7541 | 25.26 |
11:56 ET | 2656 | 25.37 |
11:58 ET | 5646 | 25.35 |
12:00 ET | 4975 | 25.328 |
12:02 ET | 7361 | 25.2853 |
12:03 ET | 2902 | 25.3 |
12:05 ET | 11730 | 25.32 |
12:07 ET | 1522 | 25.39 |
12:09 ET | 28780 | 25.51 |
12:12 ET | 9829 | 25.53 |
12:14 ET | 6439 | 25.5197 |
12:16 ET | 12437 | 25.5123 |
12:18 ET | 6844 | 25.494 |
12:20 ET | 5088 | 25.45 |
12:21 ET | 6319 | 25.425 |
12:23 ET | 3000 | 25.47 |
12:25 ET | 4049 | 25.415 |
12:27 ET | 1672 | 25.44 |
12:30 ET | 6913 | 25.44 |
12:32 ET | 7743 | 25.36 |
12:34 ET | 2849 | 25.335 |
12:36 ET | 4228 | 25.345 |
12:38 ET | 7997 | 25.2942 |
12:39 ET | 14492 | 25.31 |
12:41 ET | 2500 | 25.25 |
12:43 ET | 8970 | 25.2915 |
12:45 ET | 8695 | 25.34 |
12:48 ET | 1915 | 25.28 |
12:50 ET | 4654 | 25.28 |
12:52 ET | 5701 | 25.24 |
12:54 ET | 7907 | 25.22 |
12:56 ET | 1130 | 25.23 |
12:57 ET | 7086 | 25.29 |
12:59 ET | 6398 | 25.318 |
01:01 ET | 6283 | 25.268 |
01:03 ET | 1923 | 25.24 |
01:06 ET | 3765 | 25.23 |
01:08 ET | 4200 | 25.24 |
01:10 ET | 8335 | 25.21 |
01:12 ET | 10024 | 25.23 |
01:14 ET | 3625 | 25.19 |
01:15 ET | 2189 | 25.18 |
01:17 ET | 3817 | 25.19 |
01:19 ET | 10251 | 25.14 |
01:21 ET | 8299 | 25.18 |
01:24 ET | 3857 | 25.1399 |
01:26 ET | 3455 | 25.145 |
01:28 ET | 8390 | 25.16 |
01:30 ET | 6402 | 25.13 |
01:32 ET | 4510 | 25.17 |
01:33 ET | 8283 | 25.25 |
01:35 ET | 18765 | 25.1287 |
01:37 ET | 7059 | 25.117938 |
01:39 ET | 8877 | 25.102 |
01:42 ET | 800 | 25.125 |
01:44 ET | 5392 | 25.17 |
01:46 ET | 3779 | 25.21 |
01:48 ET | 2683 | 25.21 |
01:50 ET | 1888 | 25.22 |
01:51 ET | 8143 | 25.16 |
01:53 ET | 5572 | 25.23 |
01:55 ET | 11243 | 25.21 |
01:57 ET | 4322 | 25.24 |
02:00 ET | 8929 | 25.285 |
02:02 ET | 35025 | 25.86 |
02:04 ET | 56380 | 25.9 |
02:06 ET | 37124 | 25.93 |
02:08 ET | 43231 | 25.7 |
02:09 ET | 25244 | 25.4848 |
02:11 ET | 7479 | 25.5399 |
02:13 ET | 16276 | 25.35 |
02:15 ET | 18992 | 25.51 |
02:18 ET | 10698 | 25.62 |
02:20 ET | 23881 | 25.72 |
02:22 ET | 18454 | 25.7294 |
02:24 ET | 14185 | 25.65 |
02:26 ET | 9315 | 25.675 |
02:27 ET | 12962 | 25.645 |
02:29 ET | 16635 | 25.815 |
02:31 ET | 17300 | 25.86 |
02:33 ET | 21379 | 25.9845 |
02:36 ET | 15229 | 25.99 |
02:38 ET | 20763 | 25.82 |
02:40 ET | 11405 | 25.98 |
02:42 ET | 22862 | 25.9 |
02:44 ET | 16352 | 25.76 |
02:45 ET | 30640 | 25.55 |
02:47 ET | 10422 | 25.76 |
02:49 ET | 16256 | 25.77 |
02:51 ET | 15289 | 25.76 |
02:54 ET | 13174 | 25.835 |
02:56 ET | 9562 | 25.81 |
02:58 ET | 11224 | 25.91 |
03:00 ET | 12216 | 25.71 |
03:02 ET | 18485 | 25.55 |
03:03 ET | 12206 | 25.5 |
03:05 ET | 9459 | 25.41 |
03:07 ET | 17330 | 25.19 |
03:09 ET | 13078 | 25.275 |
03:12 ET | 16343 | 25.36 |
03:14 ET | 19597 | 25.5 |
03:16 ET | 9327 | 25.47 |
03:18 ET | 11089 | 25.42 |
03:20 ET | 7060 | 25.42 |
03:21 ET | 11750 | 25.27 |
03:23 ET | 14295 | 25.3 |
03:25 ET | 14550 | 25.35 |
03:27 ET | 20674 | 25.44 |
03:30 ET | 16279 | 25.5 |
03:32 ET | 11219 | 25.49 |
03:34 ET | 33665 | 25.47 |
03:36 ET | 14188 | 25.43 |
03:38 ET | 12254 | 25.43 |
03:39 ET | 16117 | 25.49 |
03:41 ET | 13116 | 25.4 |
03:43 ET | 16949 | 25.43 |
03:45 ET | 29756 | 25.41 |
03:48 ET | 18646 | 25.405 |
03:50 ET | 20331 | 25.32 |
03:52 ET | 21734 | 25.365 |
03:54 ET | 29638 | 25.44 |
03:56 ET | 27821 | 25.38 |
03:57 ET | 101763 | 25.3 |
03:59 ET | 383019 | 25.25 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 3.9B | 42.1x | --- |
ADMA Biologics Inc | 4.4B | 137.4x | --- |
Axsome Therapeutics Inc | 4.4B | -14.1x | --- |
Arcellx Inc | 4.2B | -76.6x | --- |
Twist Bioscience Corp | 2.8B | -12.3x | --- |
Denali Therapeutics Inc | 4.4B | -10.8x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.9B |
---|---|
Revenue (TTM) | $346.7M |
Shares Outstanding | 154.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.21 |
EPS | $0.60 |
Book Value | $1.06 |
P/E Ratio | 42.1x |
Price/Sales (TTM) | 11.2 |
Price/Cash Flow (TTM) | 40.5x |
Operating Margin | 29.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.